Axonics Inc
General ticker "AXNX" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $3.6B
Axonics Inc follows the US Stock Market performance with the rate: 46.5%.
Estimated limits based on current volatility of 0.3%: low 70.59$, high 70.96$
Factors to consider:
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [48.20$, 79.19$]
- 2024-12-30 to 2025-12-30 estimated range: [44.86$, 75.28$]
Financial Metrics affecting the AXNX estimates:
- Negative: Non-GAAP EPS, $ of -0.13 <= 0.12
- Negative: Operating profit margin, % of -6.64 <= 1.39
- Negative: Operating cash flow per share per price, % of -0.07 <= 2.58
- Negative: negative Net income
Short-term AXNX quotes
Long-term AXNX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $180.29MM | $273.70MM | $366.38MM |
| Operating Expenses | $252.10MM | $338.65MM | $392.44MM |
| Operating Income | $-71.81MM | $-64.95MM | $-26.06MM |
| Non-Operating Income | $-7.48MM | $2.63MM | $17.31MM |
| Interest Expense | $7.43MM | $2.43MM | $0.00MM |
| R&D Expense | $37.30MM | $34.41MM | $34.89MM |
| Income(Loss) | $-79.28MM | $-62.32MM | $-8.74MM |
| Taxes | $0.78MM | $-2.62MM | $-2.66MM |
| Profit(Loss) | $-80.07MM | $-59.70MM | $-6.09MM |
| Stockholders Equity | $482.44MM | $570.14MM | $637.56MM |
| Inventory | $64.95MM | $55.77MM | $79.94MM |
| Assets | $547.95MM | $659.35MM | $719.92MM |
| Operating Cash Flow | $-47.31MM | $3.19MM | $-2.02MM |
| Investing Cash Flow | $-143.00MM | $-120.35MM | $-116.90MM |
| Financing Cash Flow | $170.51MM | $133.97MM | $-3.38MM |
| Earnings Per Share* | $-1.86 | $-1.28 | $-0.12 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.